Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Aralia elata" patented technology

Aralia elata, commonly called Chinese angelica-tree, Japanese angelica-tree, and Korean angelica-tree, is a woody plant belonging to the family Araliaceae. It is known as tara-no-ki (タラノキ; 楤木) in Japanese, and dureup-namu (두릅나무) in Korean.

Composition for Preventing or Treating Muscular disease containing Aralia Elata extract

PendingKR1020260112944AAralia elataDisease
The present invention relates to a composition for the prevention or treatment of muscle diseases comprising an extract of Aralia elata. The Aralia elata extract of the present invention has the effect of enhancing grip strength, increasing muscle weight, and improving exercise performance.
Owner:KOREA INST OF SCI & TECH

Traditional Chinese medicine sustained-release granules and preparation method thereof

This invention discloses a sustained-release granule of traditional Chinese medicine and its preparation method, relating to the field of traditional Chinese medicine preparation technology. It is prepared from the following materials in parts: 100-600 parts of active extract of traditional Chinese medicine, 50-450 parts of beeswax, 20-400 parts of aralia elata gelatin, 22-400 parts of modified gelatin, 15-50 parts of polyphosphate ester, 20-220 parts of sepiolite, 10-120 parts of ethyl cellulose aqueous dispersion and 5-30 parts of calcium phosphate salt. This invention uses beeswax as a hydrophobic sustained-release barrier, which can effectively inhibit the rapid dissolution of drugs in the early stage, avoiding gastrointestinal irritation and drug efficacy fluctuations caused by a sudden increase in blood drug concentration after administration. Combined with a hydrophilic gel skeleton composed of aralia elata and modified gelatin, it slowly swells and erodes upon contact with gastrointestinal fluid, achieving a stable release of drugs in the early and middle stages. At the same time, ethyl cellulose aqueous dispersion forms a dense hydrophobic coating film, which precisely controls the drug release rate in the later stage. The multiple sustained-release mechanisms work together to overcome the poor adaptability of traditional systems and effectively avoid the problems of sudden release, delayed release, and incomplete drug release.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

A soothing and anti-hair loss hair growth liquid and its preparation method

PendingCN122075363ALong-term storage stabilityGood 5α-reductase inhibitory activityCosmetic preparationsHair cosmeticsSalvia miltiorrhizaAralia elata
This invention belongs to the field of cosmetic technology and discloses a soothing and anti-hair loss hair growth liquid and its preparation method. The hair growth liquid is composed of a compound anti-hair loss active ingredient, a scalp soothing and repairing agent, a penetration enhancer, an alcohol solvent, a surfactant, a pH adjuster, a preservative, and water. The compound anti-hair loss active ingredient is obtained by gradient ethanol extraction and concentration of five raw materials, including Platycladus orientalis leaves and Drynaria fortunei, in a specific ratio. The scalp soothing and repairing agent is obtained by decoction and concentration of raw materials such as Salvia miltiorrhiza and Aralia elata root. During preparation, the final product is obtained through stepwise extraction, density control, specific sequential compounding, and low-temperature maturation processes. This invention, through the synergy of raw materials and processes, enables the product to have good effects in preventing hair loss, promoting hair growth, and soothing the scalp, and also exhibits good stability.
Owner:GUANGZHOU ZHUOYU BIOTECHNOLOGY CO LTD

A traditional Chinese medicine composition for treating cerebrovascular diseases

PendingCN122272734ABurningbushDisease course
This invention discloses a traditional Chinese medicine composition for treating cerebrovascular diseases, belonging to the technical field of cerebrovascular disease drugs. The composition comprises the following components in parts by weight: 10-30 parts of Polygonatum sibiricum, 6-15 parts of Rosa laevigata, 6-12 parts of Euonymus alatus, 6-15 parts of Polygonum cuspidatum, 3-9 parts of Acorus tatarinowii, 3-10 parts of Alpinia oxyphylla, 3-6 parts of Aralia elata septum, 3-10 parts of Rhodiola rosea, 3-10 parts of Bletilla striata, and 1-6 parts of Cinnamomum cassia. This invention addresses the pathological characteristics of cerebrovascular diseases, including long disease courses, multiple risk factors, and involvement of multiple target organs. Through the systematic combination of ten herbs, it can simultaneously achieve cerebrovascular protection, nerve function repair, and protection against multi-organ damage. Animal experiments and clinical observations have confirmed that this composition can significantly improve patients' neurological deficit scores, reduce the incidence of complications, and has clear preventive and therapeutic effects on secondary complications such as stress ulcers and renal impairment, while also possessing antithrombotic and hemostatic properties and high safety.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Enzyme-treated product or extract of Aralia elata

ActiveJP7884921B2Cosmetic preparationsHydrolasesAralia elataEnzyme
To provide an enzyme-treated material derived from Aralia elata or its extract and a method for producing the same, and a novel composition that comprises the same as an active ingredient and has beneficial actions such as skin aging prevention.SOLUTION: The present invention relates to a material prepared by treating Aralia elata with one or more enzymes selected from the group consisting of cellulase, chitinase and protease, or its extract, a composition containing the treated material or extract, and a method for producing the treated material or extract.SELECTED DRAWING: Figure 1
Owner:KATAKURA CHIKKARIN CO LTD

A method for regulating the out-of-season water culture of young shoots of paliurus ramosissimus based on plant hormones

PendingCN122319936APlant hormoneAralia elata
This invention discloses a method for off-season hydroponic cultivation of Aralia elata buds based on plant hormone regulation, belonging to the field of hydroponic culture technology. This off-season hydroponic method optimizes the concentration ratio of indolebutyric acid (IBA), gibberellin (GA3), and salicylic acid through orthogonal experiments, combined with standardized branch pretreatment, hormone immersion, and ozone water culture management, to achieve efficient off-season cultivation of Aralia elata buds. This off-season hydroponic culture uses exogenous hormone regulation, optimized for the off-season dormancy characteristics of Aralia elata and the physiological needs of bud growth. It effectively activates the physiological metabolic pathways within the branches, quickly breaking the natural dormancy state, while providing suitable hormone guidance for bud differentiation and growth. This results in uniform bud sprouting and robust growth, solving the problems of late bud break from dormancy, slow bud growth, and large differences in growth vigor among different plants, laying a solid foundation for efficient off-season hydroponic production.
Owner:LIUPANSHUI NORMAL UNIV